BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26121929)

  • 1. Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy.
    Sciagrà R; Passeri A; Cipollini F; Castagnoli H; Olivotto I; Burger C; Cecchi F; Pupi A
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1581-8. PubMed ID: 26121929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a
    Sciagrà R; Calabretta R; Cipollini F; Passeri A; Castello A; Cecchi F; Olivotto I; Pupi A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):866-875. PubMed ID: 28050630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by
    Yalçin H; Valenta I; Yalçin F; Corona-Villalobos C; Vasquez N; Ra J; Kucukler N; Tahari A; Pozios I; Zhou Y; Pomper M; Abraham TP; Schindler TH; Abraham MR
    Am J Cardiol; 2016 Dec; 118(12):1908-1915. PubMed ID: 27771003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
    Camaioni C; Knott KD; Augusto JB; Seraphim A; Rosmini S; Ricci F; Boubertakh R; Xue H; Hughes R; Captur G; Lopes LR; Brown LAE; Manisty C; Petersen SE; Plein S; Kellman P; Mohiddin SA; Moon JC
    Heart; 2020 Jun; 106(11):824-829. PubMed ID: 31822572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography.
    Soliman OI; Knaapen P; Geleijnse ML; Dijkmans PA; Anwar AM; Nemes A; Michels M; Vletter WB; Lammertsma AA; ten Cate FJ
    Heart; 2007 Oct; 93(10):1204-12. PubMed ID: 17488767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient: a [15O]H2O PET study.
    Danad I; Raijmakers PG; Harms HJ; Heymans MW; van Royen N; Lubberink M; Boellaard R; van Rossum AC; Lammertsma AA; Knaapen P
    Eur Heart J; 2014 Aug; 35(31):2094-105. PubMed ID: 24780500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
    Knaapen P; Germans T; Camici PG; Rimoldi OE; ten Cate FJ; ten Berg JM; Dijkmans PA; Boellaard R; van Dockum WG; Götte MJ; Twisk JW; van Rossum AC; Lammertsma AA; Visser FC
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H986-93. PubMed ID: 18156203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.
    Ismail TF; Hsu LY; Greve AM; Gonçalves C; Jabbour A; Gulati A; Hewins B; Mistry N; Wage R; Roughton M; Ferreira PF; Gatehouse P; Firmin D; O'Hanlon R; Pennell DJ; Prasad SK; Arai AE
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):49. PubMed ID: 25160568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy.
    Yalcin H; Valenta I; Zhao M; Tahari A; Lu DY; Higuchi T; Yalcin F; Kucukler N; Soleimanifard Y; Zhou Y; Pomper MG; Abraham TP; Tsui B; Lodge MA; Schindler TH; Roselle Abraham M
    J Nucl Cardiol; 2019 Aug; 26(4):1243-1253. PubMed ID: 29359273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
    Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
    J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.
    Bietenbeck M; Florian A; Shomanova Z; Meier C; Yilmaz A
    Clin Res Cardiol; 2018 Nov; 107(11):1062-1070. PubMed ID: 29774406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment.
    Choudhury L; Elliott P; Rimoldi O; Ryan M; Lammertsma AA; Boyd H; McKenna WJ; Camici PG
    Basic Res Cardiol; 1999 Feb; 94(1):49-59. PubMed ID: 10097830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECT myocardial blood flow quantitation toward clinical use: a comparative study with
    Hsu B; Hu LH; Yang BH; Chen LC; Chen YK; Ting CH; Hung GU; Huang WS; Wu TC
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):117-128. PubMed ID: 27585576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully automated, inline quantification of myocardial blood flow with cardiovascular magnetic resonance: repeatability of measurements in healthy subjects.
    Brown LAE; Onciul SC; Broadbent DA; Johnson K; Fent GJ; Foley JRJ; Garg P; Chew PG; Knott K; Dall'Armellina E; Swoboda PP; Xue H; Greenwood JP; Moon JC; Kellman P; Plein S
    J Cardiovasc Magn Reson; 2018 Jul; 20(1):48. PubMed ID: 29983119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
    J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of subendocardial and subepicardial myocardial perfusion measurements in healthy normals with (15)O-labeled water and positron emission tomography.
    Vermeltfoort IA; Raijmakers PG; Lubberink M; Germans T; van Rossum AC; Lammertsma AA; Knaapen P
    J Nucl Cardiol; 2011 Aug; 18(4):650-6. PubMed ID: 21519976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Outflow Tract Contributions to 82Rb-PET Global Myocardial Blood Flow Computations.
    Van Tosh A; Reichek N; Palestro CJ; Nichols KJ
    J Nucl Med Technol; 2016 Jun; 44(2):78-84. PubMed ID: 26966126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of subendocardial and subepicardial blood flow using 15O-labeled water and PET: experimental validation.
    Rimoldi O; Schäfers KP; Boellaard R; Turkheimer F; Stegger L; Law MP; Lammerstma AA; Camici PG
    J Nucl Med; 2006 Jan; 47(1):163-72. PubMed ID: 16391201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of quantitative myocardial blood flow and
    Benz DC; Ferro P; Safa N; Messerli M; von Felten E; Huang W; Patriki D; Giannopoulos AA; Fuchs TA; Gräni C; Gebhard C; Pazhenkottil AP; Kaufmann PA; Buechel RR
    J Nucl Cardiol; 2021 Feb; 28(1):263-273. PubMed ID: 30895563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New frontiers for cardiac PET: looking beyond mean transmural myocardial quantification.
    Daou D
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1899-902. PubMed ID: 26243265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.